An Open-label Phase 1 Study to Evaluate the Safety and Efficacy of AB-1015 in Patients With Resistant/Refractory Epithelial Ovarian Cancer

Summary

 

Sponsor

Arsenal Biosciences

Status of enrollment

Open to accrual

Ages Eligible for Study

Adults ages 18 and up

Genders Eligible for Study

Female

Disease indication

Epthelial Ovarian Cancer

Principal Investigator

Edwin Alvarez, MD

Contact

Marissa Gin
 
 

Additional study eligibility details can be found at UCSF Clinical Trials